BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 10235781)

  • 1. Diagnosis and treatment of Type II and Type IV hyperlipoproteinemia in the office practice setting.
    Millett F; Sielski J; Stoll H; Alston N; Gail S
    PA J; 1976; 6(2):54-9. PubMed ID: 10235781
    [No Abstract]   [Full Text] [Related]  

  • 2. [The LDL VLDL heparin Ca++ complex and the detectability of hyperlipoproteinemia in mass examination].
    Makurat D
    Wiad Lek; 1977 Dec; 30(23):1797-800. PubMed ID: 203123
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia].
    Sauvanet JP; Drouin P; Mejean L; Lambert D; Debry G
    Therapie; 1978; 33(5):615-22. PubMed ID: 217121
    [No Abstract]   [Full Text] [Related]  

  • 4. The diagnosis and treatment of the hyperlipoproteinemias: emphasis on Types IIa, IIb and IV.
    Frommeyer WB
    Ala J Med Sci; 1974 Jul; 11(3):207-14. PubMed ID: 4375414
    [No Abstract]   [Full Text] [Related]  

  • 5. Cholesterol at birth and age 1: comparison of normal and hypercholesterolemic neonates.
    Tsang RC; Fallat RW; Glueck CJ
    Pediatrics; 1974 Apr; 53(4):458-70. PubMed ID: 4362901
    [No Abstract]   [Full Text] [Related]  

  • 6. Familial hyperlipidemias. Diagnosis and treatment.
    Fleischmajer R; Dowlati Y; Reeves JR
    Arch Dermatol; 1974 Jul; 110(1):43-50. PubMed ID: 4371196
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of hyperlipidemias.
    Murphy BF
    JAMA; 1974 Dec 23-30; 230(12):1683-91. PubMed ID: 4373590
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of a new niacin derivative (nicotinic hexaester of D-glucitol) on type IIA, IIB and IV hyperlipoproteinemia in man.
    Avogaro P; Bittolo-Bon G; Pais M; Taroni GC
    Pharmacol Res Commun; 1977 Jun; 9(6):599-606. PubMed ID: 197548
    [No Abstract]   [Full Text] [Related]  

  • 9. Neonatal diagnosis of Fredrickson type II hyperlipoproteinaemia.
    Andersen GE
    Postgrad Med J; 1975; 51(8):suppl 93-4. PubMed ID: 215988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of primary hyperlipoproteinemia types IIa, IIb and IV using beta pyridylcarbinol Study on three phases under ambulatory conditions].
    Klemens UH; von Löwis P
    Dtsch Med Wochenschr; 1973 Jun; 98(24):1197-202. PubMed ID: 4350685
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clofibrate action on the lipoprotein composition in primary type IV and type V hyperlipoproteinemia].
    Weisweiler P; Schwandt P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():398-401. PubMed ID: 206058
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diet therapy in hyperlipoproteinemias].
    Canzler H
    Z Allgemeinmed; 1974 Jan; 50(2):53-61. PubMed ID: 4361378
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of hyperlipoproteinemia type II with Xantinol-nicotinate (author's transl)].
    Haacke H; Parwaresch MR; Mäder C
    Med Klin; 1977 Jul; 72(27):1183-7. PubMed ID: 196168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Laboratory study of dyslipidemias and dyslipoproteinemias].
    Mihalache N; Georgescu M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1974; 26(8):905-13. PubMed ID: 4157095
    [No Abstract]   [Full Text] [Related]  

  • 15. Should hyperlipoproteinemia be treated in patients with coronary artery disease?
    Rider AK
    JAMA; 1975 Jul; 233(3):275-7. PubMed ID: 168412
    [No Abstract]   [Full Text] [Related]  

  • 16. The dyslipoproteinemias.
    Brown DF
    Acta Diabetol Lat; 1972 Dec; 9 Suppl 2():18-52. PubMed ID: 4369284
    [No Abstract]   [Full Text] [Related]  

  • 17. Pseudohomozygous type II hyperlipoproteinemia.
    Morganroth J; Levy RI; McMahon AE; Gotto AM
    J Pediatr; 1974 Nov; 85(5):639-43. PubMed ID: 4370845
    [No Abstract]   [Full Text] [Related]  

  • 18. [Beta-sitosterin in unsuccessfully pretreated patients with hypercholesteremia. Simultaneously, a contribution to dose dependence].
    Mühlfellner G; Mühlfellner O; Kaffarnik H
    Med Klin; 1976 Apr; 71(18):775-8. PubMed ID: 178987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The quantitative evaluation of lipid spectrum in population studies (author's transl)].
    Ricci G; Urbinati GC; Menotti A; Angelico R
    G Ital Cardiol; 1974; 4(3):341-9. PubMed ID: 4367440
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical evaluation of cinnarizine in hyperlipaemic patients.
    Saba P; Galeone F; Salvadorini F; Guarguaglini M; Houben JL
    G Clin Med; 1974 Aug; 55(8):586-99. PubMed ID: 4377134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.